Indication
Brimica Genuair is indicated as a maintenance bronchodilator treatment for airflow obstruction and relief of symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Loading your page…
Loading your page…
Pulmonary Disease, Chronic Obstructive
Marketing Authorisation Holder: Covis Pharma Europe B.V.
EMA Authorisation: 19/11/2014
INN: aclidinium;formoterol fumarate dihydrate
AI Drug & Interaction Analysis
Free account required
Ask Osler about Brimica Genuair: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.